Cargando…
Involvement of Vasopressin in the Pathogenesis of Pulmonary Tuberculosis: A New Therapeutic Target?
Tuberculosis (TB) is a highly complex infectious disease caused by the intracellular pathogen Mycobacterium tuberculosis (Mtb). It is characterized by chronic granulomatous inflammation of the lung and systemic immune–neuroendocrine responses that have been associated with pathophysiology and diseas...
Autores principales: | Zetter, Mario, Barrios-Payán, Jorge, Mata-Espinosa, Dulce, Marquina-Castillo, Brenda, Quintanar-Stephano, Andrés, Hernández-Pando, Rogelio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6563385/ https://www.ncbi.nlm.nih.gov/pubmed/31244771 http://dx.doi.org/10.3389/fendo.2019.00351 |
Ejemplares similares
-
Structural homology between 11 beta-hydroxysteroid dehydrogenase and Mycobacterium tuberculosis Inh-A enzyme: Dehydroepiandrosterone as a potential co-adjuvant treatment in diabetes-tuberculosis comorbidity
por: Hernández-Bustamante, Israel, et al.
Publicado: (2023) -
The Therapeutic Effect of Intranasal Administration of Dexamethasone in Neuroinflammation Induced by Experimental Pulmonary Tuberculosis
por: Lara-Espinosa, Jacqueline V., et al.
Publicado: (2021) -
A significant therapeutic effect of silymarin administered alone, or in combination with chemotherapy, in experimental pulmonary tuberculosis caused by drug-sensitive or drug-resistant strains: In vitro and in vivo studies
por: Rodríguez-Flores, Edén M., et al.
Publicado: (2019) -
The Role of High Mobility Group Box 1 Protein (HMGB1) in the Immunopathology of Experimental Pulmonary Tuberculosis
por: Hernández-Pando, Rogelio, et al.
Publicado: (2015) -
Correction: The Role of High Mobility Group Box 1 Protein (HMGB1) in the Immunopathology of Experimental Pulmonary Tuberculosis
por: Hernández-Pando, Rogelio, et al.
Publicado: (2015)